NSRX Nasus Pharma Ltd.
Company Analysis
Latest News
🔴 Nasus Pharma is trading 9% down today after wider first-half losses
Nasus Pharma is trading 8.97% down now at $3.37 after its August 17, 2026, first-half results showed a net loss widening to $5.9 million from $1.3 million year...
🔴 Nasus Pharma is trading 5.65% down today after first-half results showed wider net loss and going-concern risk
Nasus Pharma is trading at $3.42, down 5.65%, after releasing first-half 2026 financial results on August 17, 2026: - Net loss widened to $5.9 million from...
🟢 Nasus Pharma is trading 11.25% up today — reason unconfirmed
Nasus Pharma is trading at $3.56 (+11.25%), with the reason unconfirmed. - No company-specific announcement, filing, earnings release, or analyst action was...
🟢 Nasus Pharma is trading 7.5% up today with no clear catalyst identified
Nasus Pharma is trading 7.5% up at $3.44, with no clear catalyst identified. - The stock closed at $3.20 on August 13, 2026. - No company-specific...
🔴 Nasus Pharma is trading 5.04% down in after-hours trading on August 13, 2026
Nasus Pharma is trading 5.04% down at $3.20 after closing the regular session at $3.37, with no company-specific catalyst identified. - Searches found no...
🟢 Nasus Pharma is trading 7.15% up today amid broader risk-on market sentiment
Nasus Pharma is trading 7.15% higher at $3.47, amid a broader risk-on session. - The S&P 500 and Nasdaq Composite are both rising more than 0.5%. - No clear...
🔴 Nasus Pharma is trading 5.82% down today; no clear catalyst identified
Nasus Pharma is trading 5.82% down at $3.05, with the immediate reason unclear. - No new August 13, 2026 company announcement, filing, analyst action, or...
🔴 Nasus Pharma is trading 5% down today with no clear company-specific catalyst identified
Nasus Pharma is trading at $3.28, down 5.07%, with no clear company-specific announcement identified for August 10, 2026. • The June 9 NS003 preclinical...
🔴 Nasus Pharma is trading 7.38% down in pre-market; no clear company-specific announcement identified
Nasus Pharma is trading 7.38% down at $3.20 after no clear company-specific announcement was identified for August 10, 2026. - Latest notable update: Brendan...
🔴 Nasus Pharma is trading 6.63% down today
Nasus Pharma is trading 6.63% down at $3.10 after falling from the August 5 close of $3.32, with no clear catalyst identified. - Searches found no new...
🟢 Nasus Pharma is trading 5.4% up today amid volatile small-cap trading
Nasus Pharma is trading 5.4% up now at $3.50 after rebounding from the August 5 close of $3.32. - Available coverage does not identify a new company-specific...
🔴 Nasus Pharma is trading 9.1% down today in a pullback after a two-day rally
Nasus Pharma is trading 9.1% down at $3.18 today in an apparent pullback following a sharp two-day rally and in the absence of any fresh, company-specific news...
🟢 Nasus Pharma is trading 6.1% up today, extending its rally amid strong risk-on sentiment
Nasus Pharma is trading at $3.50 (up 6.1%) in after-hours sessions, extending a multi-day rally driven by broader market strength and thin liquidity. • The...
🟢 Nasus Pharma is trading 5.4% up today as broader U.S. equities rally
Nasus Pharma is trading at $3.36, up 5.4% today as broader U.S. equities rally sharply despite a lack of fresh company-specific catalysts. • The upward move...
🟢 Nasus Pharma is trading 6.7% up today amid broad market rally and thin after-hours liquidity
Nasus Pharma is trading at $3.19 (+6.69%) in after-hours trading following a session with no company-specific catalysts, earnings releases, or late-breaking...
🟢 Nasus Pharma is trading 5.28% up today amid a broad risk-on market rally
Nasus Pharma is trading at $3.19 (+5.28%) following a broad risk-on move in U.S. equities, as no company-specific news was identified to drive the price...
🔴 Nasus Pharma is trading 5.9% down today after yesterday’s CEO appointment rally
Nasus Pharma is trading 5.9% down today at $3.02 as the stock gives back a portion of its gains following a sharp rally on July 29. • The previous surge was...
Nasus Pharma Appoints Former Teva USA CEO, Eyes $2B Treatment Launch
Nasus Pharma appointed Brendan P. O'Grady as Chief Executive Officer, effective July 27, 2026. O'Grady succeeds Dan Teleman as the company advances its lead...
🔴 Nasus Pharma is trading 5.1% down today amid broader Nasdaq weakness
Nasus Pharma is trading at $2.96 (-5.12%) as broader market pressure and Nasdaq weakness weigh on smaller growth names. • No company-specific catalysts, such...
🟢 Nasus Pharma is trading 8.5% up today on momentum-driven speculative volatility
Nasus Pharma is trading 8.5% up today at $3.18 on momentum-driven speculative volatility, continuing a trend of sharp price swings seen over the past week. •...